Home » Stocks » ZBH

Zimmer Biomet Holdings, Inc. (ZBH)

Stock Price: $152.60 USD -5.62 (-3.55%)
Updated Jan 27, 2021 4:00 PM EST - Market closed
Market Cap 32.80B
Revenue (ttm) 7.06B
Net Income (ttm) -151.90M
Shares Out 207.10M
EPS (ttm) -0.74
PE Ratio n/a
Forward PE 20.37
Dividend $0.96
Dividend Yield 0.63%
Trading Day January 27
Last Price $152.60
Previous Close $158.22
Change ($) -5.62
Change (%) -3.55%
Day's Open 155.23
Day's Range 152.02 - 157.72
Day's Volume 1,890,046
52-Week Range 79.99 - 163.46

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
PRNewsWire - 6 days ago

STOCKHOLM, Jan. 21, 2021 /PRNewswire/ -- Today, Bactiguard-coated Zimmer Biomet orthopaedic trauma implants received European regulatory clearance and CE mark. Preparations for registering the...

PRNewsWire - 1 week ago

WARSAW, Ind., Jan. 19, 2021 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced that Ellison (Ellie) M. Humphrey ha...

CNBC Television - 1 week ago

Final Trades: Pfizer, Devon Energy, Zimmer & more

The "Halftime Report" traders give their top picks to watch for the second half.

Other stocks mentioned: DVN, PFE, VWDRY
PRNewsWire - 2 weeks ago

WARSAW, Ind., Jan. 8, 2021 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced its fourth quarter earnings conference call will be webcast on Friday, February 5, 2...

Zacks Investment Research - 3 weeks ago

Zimmer Biomet (ZBH) is performing well in its priority areas like quality remediation, supply recovery efforts and product introductions.

CNBC Television - 1 month ago

Final Trades: Home Depot, Zimmer Holdings, Tractor Supply & more

The "Halftime Report" traders give their top picks to watch for the second half.

Other stocks mentioned: HD, TSCO, RMD, UNFI
Zacks Investment Research - 1 month ago

Owing to lack of clarity around the scope and duration of the coronavirus pandemic, Zimmer Biomet (ZBH) is unable to gauge the impact on its overall business in 2020.

PRNewsWire - 1 month ago

WARSAW, Ind., Dec. 16, 2020 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced that its Board of Directors has app...

PRNewsWire - 1 month ago

WARSAW, Ind., Dec. 14, 2020 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced that President and CEO Bryan Hanson...

CNBC - 1 month ago

TipRanks analyst ranking service pinpoints Wall Street's best-performing stocks, like Marvell and Campbell Soup.

Other stocks mentioned: CPB, EVOP, HUBG, MRVL
Zacks Investment Research - 1 month ago

Zimmer Biomet's (ZBH) mymobility with Apple Watch platform aids in transforming virtual patient care via the latest partnership with HSS.

Zacks Investment Research - 1 month ago

Let's see if Zimmer Biomet (ZBH) stock is a good choice for value-oriented investors right now from multiple angles.

Benzinga - 1 month ago

The benefits of reopening post-pandemic have not yet been factored in for these four stocks relative to their earnings, according to UBS analysts.

Other stocks mentioned: ADS, CHH, TRIP
Zacks Investment Research - 1 month ago

Zimmer (ZBH) reported earnings 30 days ago. What's next for the stock?

Zacks Investment Research - 1 month ago

This latest development aligns with Zimmer Biomet's (ZBH) active portfolio management strategy and the ongoing transformation of business aimed at long-term growth.

Business Wire - 1 month ago

LOS ANGELES--(BUSINESS WIRE)--Vance Street Capital LLC (“Vance Street”) is pleased to announce it has completed the sale of A&E Medical Corporation (“A&E Medical”) to Zimmer Biomet (NYSE: ZBH)...

PRNewsWire - 1 month ago

WARSAW, Ind., Dec. 1, 2020 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today officially launched the Zimmer Biomet Foundati...

Seeking Alpha - 2 months ago

Zimmer Biomet has exited the 3rd quarter better than expected, with tailwinds in hips and knees globally to drive top-line growth in years to come. The ROSA and Persona Revision segments have ...

Seeking Alpha - 2 months ago

Zimmer Biomet Holdings, Inc. (ZBH) CEO Bryan Hanson on Q3 2020 Results - Earnings Call Transcript

The Motley Fool - 2 months ago

The company's recovery from the coronavirus pandemic was better than expected.

Zacks Investment Research - 2 months ago

Zimmer Biomet (ZBH) registers stronger-than-expected recovery of elective procedures in the third quarter.

Zacks Investment Research - 2 months ago

Zimmer (ZBH) delivered earnings and revenue surprises of 72.38% and 12.50%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

Benzinga - 2 months ago

  Shares of Zimmer Biomet Holdings (NYSE:ZBH) were unchanged after the company reported Q3 results.

PRNewsWire - 2 months ago

WARSAW, Ind., Nov. 6, 2020 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today reported financial results for the quarter ended September 30, 2020. The Company reported thir...

PRNewsWire - 2 months ago

WARSAW, Ind., Nov. 5, 2020 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced preliminary results from a prospecti...

Zacks Investment Research - 2 months ago

Several medical product stocks have come up with bullish earnings reports so far this reporting cycle. Let's see how ZBH, HRC and HMS are poised ahead of their announcements.

Other stocks mentioned: HMSY, HRC
Zacks Investment Research - 2 months ago

Zimmer Biomet (ZBH) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Zacks Investment Research - 2 months ago

Here we discuss three medical product stocks that are due to report soon and are likely to beat estimates on earnings, on the back of several factors.

Other stocks mentioned: ABT, CGC, MDT
Zacks Investment Research - 2 months ago

Zimmer Biomet's (ZBH) Dental product volumes are expected to have declined significantly in the third quarter due to the extremely elective nature of the products.

PRNewsWire - 2 months ago

WARSAW, Ind., Nov. 2, 2020 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal care, today announced that President and CEO Bryan Hanson and Ex...

Zacks Investment Research - 2 months ago

Zimmer (ZBH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

CNBC Television - 3 months ago

Final Trades: Starbucks, Facebook, Zimmer Holdings & more

The "Halftime Report" traders give their top picks to watch for the second half.

Other stocks mentioned: SBUX, FB, XLI
PRNewsWire - 3 months ago

WARSAW, Ind., Oct. 6, 2020 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced its third quarter earnings conference call will be webcast on Friday, November 6, 20...

24/7 Wall Street - 3 months ago

While technology has been the engine that has driven stock market performance for some time now, increasingly we are seeing a seismic shift to health care among many portfolio managers, and wi...

Other stocks mentioned: ABBV, BSX, MDT, SYK
PRNewsWire - 4 months ago

WARSAW, Ind., Sept. 10, 2020 /PRNewswire/ -- Zimmer Biomet Holdings, Inc.

PRNewsWire - 4 months ago

WARSAW, Ind., Sept. 8, 2020 /PRNewswire/ -- Zimmer Biomet Holdings, Inc.

Zacks Investment Research - 4 months ago

Zimmer (ZBH) reported earnings 30 days ago. What's next for the stock?

Zacks Investment Research - 4 months ago

Let us delve deeper to get an insight into the not-so-talked-about but intense threats to MedTech.

Other stocks mentioned: ABT, GE, MDT, MYGN
CNBC Television - 5 months ago

Final Trades: Zimmer Holdings, Berkshire Hathaway, XPO Logistics & more

The "Halftime Report" traders give their top picks to watch for the second half.

Other stocks mentioned: BRK.A, BRK.B, XPO, OLLI
Seeking Alpha - 5 months ago

Zimmer Biomet Holdings, Inc. (ZBH) CEO Bryan Hanson on Q2 2020 Results - Earnings Call Transcript

Zacks Investment Research - 5 months ago

Zimmer Biomet's (ZBH) second-quarter elective procedure volumes decline across all regions.

Zacks Investment Research - 5 months ago

Zimmer (ZBH) delivered earnings and revenue surprises of 106.94% and 31.71%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

PRNewsWire - 5 months ago

WARSAW, Ind., Aug. 4, 2020 /PRNewswire/ -- Zimmer Biomet Holdings, Inc.

Zacks Investment Research - 5 months ago

Zimmer Biomet (ZBH) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Zacks Investment Research - 5 months ago

Zimmer (ZBH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Zacks Investment Research - 5 months ago

Zimmer (ZBH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Investment Research - 5 months ago

Zimmer Biomet's (ZBH) Hips and Knees portfolios are expected to have contributed to second-quarter top line despite pandemic-led business disruptions.

Benzinga - 6 months ago

Zimmer Biomet Holdings Inc (NASDAQ: ZBH) shares are trading higher on Wednesday after SVB Leerink maintained a Buy rating on the stock and raised its price target from $136 to $146.

The Motley Fool - 6 months ago

The pandemic hit Zimmer, Smith+Nephew, and Stryker hard -- but they'll soon rise again.

Other stocks mentioned: SNN, SYK
Zacks Investment Research - 6 months ago

Medical Products Industry's Near-Term Outlook Lacks Spark

Other stocks mentioned: ABT, BAX, BSX, HRC, ISRG, MDT, PRGO, RMD, SYK

About ZBH

Zimmer Biomet Holdings, together with its subsidiaries, designs, manufactures, and markets musculoskeletal healthcare products and solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in four segments: Spine, less Asia Pacific; Office Based Technologies; Craniomaxillofacial and Thoracic; and Dental. The company provides orthopaedic reconstructive products, such as knee and hip replacement products; S.E.T. products, including surgical, sports medicine, biologics, foot and ankle, extremities, and trauma pr... [Read more...]

Industry
Medical Devices
Founded
1927
CEO
Bryan Hanson
Employees
19,900
Stock Exchange
NYSE
Ticker Symbol
ZBH
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecasts

According to 30 analysts, the average rating for Zimmer Biomet stock is "Buy." The 12-month stock price forecast is 168.30, which is an increase of 10.29% from the latest price.

Price Target
$168.30
(10.29% upside)
Analyst Consensus: Buy